Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome

被引:23
作者
Fisher, AM [1 ]
Strike, P
Scott, C
Moorman, AV
机构
[1] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England
[2] Salisbury Dist Hosp, Res & Dev Support Unit, Salisbury SP2 8BJ, Wilts, England
[3] Churchill Hosp, Chromosome Abnormal Database, Genet Labs, Oxford OX3 7LJ, England
[4] Univ Southampton, Canc Sci Div, LRF Cytogenet Grp, Southampton, Hants, England
关键词
D O I
10.1002/gcc.20196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
From 5% to 10% of 9;22 translocations in chronic myeloid leukemia (CML) are reported to occur in variant form, that is, with the involvement of other regions of the genome in 3-way or more rearrangements. The literature indicates that the alternative breakpoints are not distributed randomly in the genome but show hotspots. We present data on 289 unpublished cases of CML with variant 9;22 translocations having a total of 342 variant breakpoints, the largest independent series to date. We found that the distribution of breaks was in loose agreement with the literature but that some new hotspots were identified; furthermore, some published hotspots were not fully supported by our data. Moreover, when our 342 variant breakpoints were plotted against profiles of CG heterogeneity in the genome, a significant positive correlation between breakpoint locations and CG composition was observed. In an ancillary study, we compared the frequency of variant t(9;22) with that of variants of t(15;17) associated with acute promyelocytic leukemia (AML M3). We found that the frequency of the former, 9.3%, was significantly higher than that of the latter, 2.6%. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 34 条
[1]  
BERNHEIM A, 1990, CANCER GENET CYTOGEN, V44, P169
[2]   Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial [J].
Burnett, AK ;
Grimwade, D ;
Solomon, E ;
Wheatley, K ;
Goldstone, AH .
BLOOD, 1999, 93 (12) :4131-4143
[3]   The human transcriptome map:: Clustering of highly expressed genes in chromosomal domains [J].
Caron, H ;
van Schaik, B ;
van der Mee, M ;
Baas, F ;
Riggins, G ;
van Sluis, P ;
Hermus, MC ;
van Asperen, R ;
Boon, K ;
Voûte, PA ;
Heisterkamp, S ;
van Kampen, A ;
Versteeg, R .
SCIENCE, 2001, 291 (5507) :1289-+
[4]  
Cohen O, 1996, HUM GENET, V97, P659
[5]   Finishing the euchromatic sequence of the human genome [J].
Collins, FS ;
Lander, ES ;
Rogers, J ;
Waterston, RH .
NATURE, 2004, 431 (7011) :931-945
[6]   Expression patterns and gene distribution in the human genome [J].
D'Onofrio, G .
GENE, 2002, 300 (1-2) :155-160
[7]   STRUCTURAL DIFFERENCES IN RECIPROCAL TRANSLOCATIONS - POTENTIAL FOR A MODEL OF RISK IN RCP [J].
DANIEL, A .
HUMAN GENETICS, 1979, 51 (02) :171-182
[8]   VARIANT PHILADELPHIA TRANSLOCATIONS IN CHRONIC MYELOID-LEUKEMIA [J].
DEBRAEKELEER, M .
CYTOGENETICS AND CELL GENETICS, 1987, 44 (04) :215-222
[9]   The molecular biology of chronic myeloid leukemia [J].
Deininger, MWN ;
Goldman, JM ;
Melo, JV .
BLOOD, 2000, 96 (10) :3343-3356
[10]   Local rates of recombination are positively correlated with GC content in the human genome [J].
Fullerton, SM ;
Carvalho, AB ;
Clark, AG .
MOLECULAR BIOLOGY AND EVOLUTION, 2001, 18 (06) :1139-1142